University of Sydney researchers have been awarded $1.12 million in funding to undertake clinical studies into needle-free vaccine delivery for ‘at-risk groups’.

Dissolvable microneedle patches are predicted to be the wave of the future, and the same products are being used overseas to examine successful adoption of barcoded ‘vaccine tattoos’.

[…Continued]